BASF sells food and health performance ingredients business to Louis Dreyfus Company
Divestment is part of BASF’s strategic portfolio optimization
Divestment is part of BASF’s strategic portfolio optimization
Divalproex Sodium Delayed-Release Capsules USP, 125 mg have an estimated market size of US$ 61.1 million for twelve months ending September 2024 according to IQVIA
The company has received the GMP Certification after successful closure of the inspection
The company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
This facility marks a significant milestone in transforming the global food industr
Difluprednate Ophthalmic Emulsion, 0.05% is a topical corticosteroid that is indicated in the treatment of inflammation and pain associated with ocular surgery
SPARC to receive 55% equity in Tiller Therapeutics
Kiran Mazumdar-Shaw received the award from Janak Kumar Mehta, President of ISQ and Chairman & Managing Director, TQM International
Subscribe To Our Newsletter & Stay Updated